This is a great one to short, with so much downside. There are no near-term price catalysts, and a valuation model points to $3 being optimistic for this fledgling biotech. I can't see current levels as anything other than wild speculation.
PGL Price at posting:
0.0¢ Sentiment: None Disclosure: Not Held
